Although MED1 overexpression itself does not induce mammary tumor formation, we observed significantly promoted tumor onset, growth, metastasis, and elevated primary tumor multiplicity in MMTV-HER2/MMTV-MED1 double-transgenic mice. The gene discussed is ERBB2; the disease is neoplasm.